New Delhi:Â Drug firm Eli Lilly and Company on Monday said it has inked voluntary licensing agreements with Indian drug firms — Sun Pharma, Cipla and Lupin — to expedite availability of its arthritis drug Baricitinib for treatment of COVID-19 patients in India. The company “has issued royalty-free, non-exclusive voluntary licenses to established Indian pharmaceutical manufacturers […]
